|
H1 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$3,833.33
|
|
H3400 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H3401 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S3 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S1800 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H3538 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H3452 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S1812 An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H27 An Act Making Uniform the Law Regarding Trade Secrets
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H729 An Act Establishing the Commission on Extended Producer Responsibility
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S386 An Act Establishing the Commission on Extended Producer Responsibility
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H825 An Act Regulating the Disposal of Prescription Medication
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H925 An Act Relative to Mandated Benefits
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1004 An Act Relative to Controlling Health Care Costs in the Commonwealth
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1019 An Act Making Greater Use of Managed Care in Medicaid
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1023 An Act to Protect Healthcare Reform Funding
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S554 An Act to Protect Healthcare Reform Funding
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1052 An Act Relative to Prescription Drugs
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1268 An Act to Increase Access to Vaccines
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1676 An Act Criminalizing the Possession of Ingredients for Manufactured Drugs
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1927 An Act Relative to the Substitution of Interchangeable Biosimilars
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$1,916.67
|
|
H1933 An Act Establishing Provisions for the Return of Expired Pharmaceuticals
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1940 An Act Relative to Safe Disposal of Medical Sharps
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1953 An Act Promoting Research and Protecting Public Safety and Environment
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1956 An Act to Establish a Statewide Program to Promote Prevention, Diagnosis and Treatment of Type 2 Diabetes
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1962 An Act Relative to the Substitution of Generic Drugs
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1977 An Act Relative to Drug Disposal by Mail Prescriptions
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1988 An Act Relative to Suspending Prescription Drug Coverage from Minimum Creditable Coverage
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1995 An Act Providing for Unused Medication Return by Health Care Facilities
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2012 An Act Establishing the Massachusetts Childhood Vaccine Program
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$1,150.00
|
|
S534 An Act Establishing the Massachusetts Childhood Vaccine Program
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$766.67
|
|
S1922 An Act Establishing the Massachusetts Childhood Vaccine Program
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2018 An Act to Define Modest Meals and Refreshments in Prescriber Educational Settings
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$1,916.67
|
|
H2020 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S1050 An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2033 An Act Relative to Safe Disposal of Prescription Drugs
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2061 An Act Prohibiting Advertising by Pharmaceutical Companies
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2081 An Act Providing for the Establishment and Operation of a Cancer Drug Repository Program
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2082 An Act Establishing a Statewide Discount Program for Pharmaceuticals
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S1094 An Act Establishing a Statewide Discount Program for Pharmaceuticals
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2096 An Act Establishing a Special Commission to Study and Recommend Improvements in the Delivery of Prescription Drug Benefits for the Citizens of the Commonwealth
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2108 An Act Relative to School Located Influenza Vaccination Programs
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H2112 An Act Relative to Provider Choice and Reliable Vaccine Management
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$1,916.67
|
|
H2646 An Act to Eliminate the Tax Deduction for Direct to Consumer Pharmaceutical Marketing
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H3452 An Act Implementing the Affordable Care Act and Providing Further Access to Affordable Health Care
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H3667 An Act Relative to the Substitution of Interchangeable Biosimilars
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H3734 An Act Relative to the Substitution of Interchangeable Biosimilars
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$1,916.67
|
|
S300 An Act Relative to the Prescription Drug Covergae for Seniors and the Disabled
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S439 An Act Relative to Patient Medication Adherence
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S477 An Act Relative to Patient Protection
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S484 An Act Regulating Pharmacists as Health Care Providers
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S499 An Act Concerning Medicaid and Accountable care
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S514 An Act Establishing a Public Health Insurance Option
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S543 An Act to Ensure the Privacy of Patient Prescription Records
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S544 An Act Improving Access to Coverage for Medicaid Beneficiaries
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
H1018 An Act Improving Access to Coverage for Medicaid Beneficiaries
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S569 An Act Relative to Mandatory Prescription Drug Coverage
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S572 An Act to Ensure Effective Health Care Cost Control
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S917 An Act Relative to Emergency Scheduling of Addictive Substances by the Commissioner of Public Health
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$1,916.67
|
|
H3711 An Act Relative to Emergency Scheduling of Addictive Substances by the Commissioner of Public Health
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$1,916.67
|
|
H3547 An Act Relative to Emergency Scheduling of Addictive Substances by the Commissioner of Public Health
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S1021 An Act to Increase Access to Vaccines
|
Support
|
N/A
| Merck Sharp & Dohme Corp. |
$1,916.67
|
|
S1051 An Act to Prevent Undue Influence on Prescriber Behavior
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S1052 An Act to Restore Integrity in the Marketing of Pharmaceutical Products and Medical Devices
|
Oppose
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
S1360 An Act Relative to Tax Credits for Prescription Drugs
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.26
|
|
Chapter 224 the Acts of 2012 An Act Improving The Quality Of Health Care and Reducing Costs Through Increased Transparency, Efficiency and Innovation
|
Neutral
|
N/A
| Merck Sharp & Dohme Corp. |
$342.34
|
| | | | Total amount |
$38,333.33
|